Literature DB >> 16194737

Total shoulder arthroplasty: long-term survivorship, functional outcome, and quality of life.

Ashwin V Deshmukh1, Mark Koris, David Zurakowski, Thomas S Thornhill.   

Abstract

This study examines long-term outcomes of total shoulder arthroplasty (TSA) via survivorship analysis, patient questionnaires, and minimum 10-year physical examinations. The study group consisted of 320 consecutive TSAs performed in 267 patients between 1974 and 1988. Diagnoses included rheumatoid arthritis (69%), osteoarthritis (22%), and juvenile rheumatoid arthritis (4.7%). Minimum 10-year physical examination follow-up was obtained on a subset of 72 TSAs at a mean (+/- SD) of 14.0 +/- 2.7 years. A Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire was obtained from 80 patients with 103 TSAs at a mean of 15.4 +/- 3.4 years after the index procedure (range, 10.4-23.2 years). Kaplan-Meier survivorship rates with revision as the endpoint at 5, 10, 15, and 20 years were 98%, 93%, 88%, and 85%, respectively. Of the shoulders, 22 (6.9%) required a revision, most commonly for loosening of one or both components (15 shoulders). Dislocation occurred earlier than other causes of revision or complication (P < .05, analysis of variance). Minimum 10-year physical examination follow-up revealed lasting, significant improvements in range of motion and strength. The patients' subjective assessments of TSA were favorable in that 92% felt that their shoulder was "much better" or "better" after TSA. The mean DASH score was 49 +/- 25; no significant differences were found among diagnoses. Long-term analysis of the Neer-type TSA revealed survivorship rates comparable to other joint replacements. The significant improvements in relief of pain, shoulder range of motion, and strength are associated with a high degree of patient satisfaction.

Entities:  

Mesh:

Year:  2005        PMID: 16194737     DOI: 10.1016/j.jse.2005.02.009

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  87 in total

1.  Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes.

Authors:  Jasvinder A Singh; Rekha Ramachandran
Journal:  J Racial Ethn Health Disparities       Date:  2015

2.  Stemless shoulder arthroplasty-current results and designs.

Authors:  R Sean Churchill; George S Athwal
Journal:  Curr Rev Musculoskelet Med       Date:  2016-03

3.  Stemless shoulder arthroplasty: a literature review.

Authors:  Dario Petriccioli; Celeste Bertone; Giacomo Marchi
Journal:  Joints       Date:  2015-06-08

Review 4.  [Results for endoprosthetic care in patients younger than 50 years].

Authors:  J Ziegler; M Amlang; M Bottesi; S Kirschner; W-C Witzleb; K-P Günther
Journal:  Orthopade       Date:  2007-04       Impact factor: 1.087

5.  Total shoulder arthroplasty in older patients: increased perioperative morbidity?

Authors:  Eric T Ricchetti; Joseph A Abboud; Andrew F Kuntz; Matthew L Ramsey; David L Glaser; Gerald R Williams
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

Review 6.  [The dislocated shoulder prosthesis--an avoidable disaster?].

Authors:  J Hausdorf; M Pietschmann; V Jansson; P E Müller
Journal:  Orthopade       Date:  2007-10       Impact factor: 1.087

Review 7.  Shoulder arthroplasty.

Authors:  Florian M Buck; Bernhard Jost; Juerg Hodler
Journal:  Eur Radiol       Date:  2008-07-11       Impact factor: 5.315

8.  Shoulder Arthroplasty for Humeral Head Avascular Necrosis Is Associated With Increased Postoperative Complications.

Authors:  M Tyrrell Burrus; Jourdan M Cancienne; Jeffrey D Boatright; Scott Yang; Stephen F Brockmeier; Brian C Werner
Journal:  HSS J       Date:  2017-05-15

9.  Glenoid bone loss in primary and revision shoulder arthroplasty.

Authors:  Amar Malhas; Abbas Rashid; Dave Copas; Steve Bale; Ian Trail
Journal:  Shoulder Elbow       Date:  2016-05-06

10.  Outcomes of shoulder arthroplasty in diabetic patients as assessed by peri-operative A1C.

Authors:  Joseph M Statz; Eric R Wagner; John W Sperling; Robert H Cofield
Journal:  Int Orthop       Date:  2018-03-18       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.